Research initiatives play a meaningful role in many oncology clinics by incorporating clinical trials and observational studies into patient care options. These research activities may contribute to expanding knowledge about emerging therapies and diagnostic methods. Clinics participating in research often adhere to regulatory frameworks governed by Mexican health authorities such as COFEPRIS.

Participation in clinical research within oncology clinics involves systematic protocols to ensure patient safety and data integrity. Eligibility criteria for clinical trials typically include cancer type, stage, and prior treatments, and enrollment is considered after routine clinical options are evaluated. These studies may test novel drugs, combinations, or treatment regimens in controlled settings.
Research involvement can also intersect with standard care pathways, with some institutions providing access to investigational treatments alongside established protocols. This approach allows clinics to contribute to scientific evidence while offering diverse treatment possibilities under professional oversight.
The extent of research activity varies among clinics in Mexico depending on institutional capacity, funding, and specialist availability. Academic medical centers and larger oncology institutions often have more active research programs compared to smaller clinics, which may focus primarily on established treatment provisions.